Moderna monovalent Omicron XBB.1.5 COVID-19 vaccine safety data – all participants

Data on this page show the responses of individuals who received the Moderna monovalent Omicron XBB.1.5 (registered for use in people aged 12 years and over) COVID-19 vaccine and completed an AusVaxSafety survey sent on day 3 after vaccination. Note: The Moderna monovalent Omicron XBB.1.5 COVID-19 vaccine is no longer being administered in Australia; therefore, Moderna monovalent Omicron XBB.1.5 COVID-19 vaccine safety data below are no longer updated. AusVaxSafety has retained the display of historical Moderna monovalent Omicron XBB.1.5 COVID-19 vaccine safety data as a reference.

AusVaxSafety’s active vaccine safety surveillance system complements the enhanced safety surveillance activities of the Therapeutic Goods Administration (TGA). Find out more about how the TGA monitors the safety of vaccines and how you can report side effects on the TGA website.
 
Click here to view ATAGI’s recommendations on the use of XBB.1.5 COVID-19 vaccines